Home drug delivery considered a 'key initiative' for Marken

Why go to the clinical trial, when you could bring the trial home to you? Offering a home delivery service for clinical subjects is a concept supply chain service provider Marken is looking at possibly using, as an Outsourcing-Pharma story shows.

The notion isn't unusual, as pharma giant Pfizer ($PFE) has tried remote trial testing, an experiment that had its ups and downs. What Marken envisions is shipping pharmaceuticals directly to the homes of the subjects, rather than bringing the subjects to sites. It's a service that Marken has already toyed with through a limited number of trials in some countries, Senior Vice President of Commercial Operations Ariette van Strien tells Outsourcing-Pharma.

"We cannot commit to a final timeline as each country will have its specific legal and regulatory requirements, but it is a key initiative for Marken," said van Strien, as quoted by Outsourcing-Pharma.

While remote testing can raise questions, it could help take the growing company to new heights. As Marken evolves through its recent acquisition of LabCorp's sampling kit sector, as well as the launch of new sites and online inventory and diagnostics tools, offering this new service can set it apart not only from its contemporaries, but another group of possible competitors: global shipping giants, like World Courier, UPS, DHL and FedEx, all of which have made investments in trial logistics, the article highlights.

- get more from Outsourcing-Pharma

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.